In summary, the results presented here demonstrate that morusin inhibits proliferation and tumor growth by down-regulating c-Myc in gastric cancer and might be a potential neoadjuvant chemotherapy or an alternative strategy for treating gastric cancer patients. The gene discussed is MYC; the disease is neoplasm.